7782 related articles for article (PubMed ID: 11832527)
21. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A; Nicolaides KH; Balani J; Hyer S; Akolekar R; Kotecha R; Pastides A; Shehata H
N Engl J Med; 2016 Feb; 374(5):434-43. PubMed ID: 26840133
[TBL] [Abstract][Full Text] [Related]
22. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
[TBL] [Abstract][Full Text] [Related]
24. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
25. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
Diabetes Prevention Program Research Group
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
[TBL] [Abstract][Full Text] [Related]
26. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.
O'Brien MJ; Whitaker RC; Yu D; Ackermann RT
Prev Med; 2015 Aug; 77():125-30. PubMed ID: 26024851
[TBL] [Abstract][Full Text] [Related]
27. Relationship of body size and shape to the development of diabetes in the diabetes prevention program.
Diabetes Prevention Program Research Group
Obesity (Silver Spring); 2006 Nov; 14(11):2107-17. PubMed ID: 17135629
[TBL] [Abstract][Full Text] [Related]
28. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial.
Zhang L; Zhang Y; Shen S; Wang X; Dong L; Li Q; Ren W; Li Y; Bai J; Gong Q; Kuang H; Qi L; Lu Q; Cheng W; Liu Y; Yan S; Wu D; Fang H; Hou F; Wang Y; Yang Z; Lian X; Du J; Sun N; Ji L; Li G;
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):567-577. PubMed ID: 37414069
[TBL] [Abstract][Full Text] [Related]
29. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
Toplak H; Hamann A; Moore R; Masson E; Gorska M; Vercruysse F; Sun X; Fitchet M
Int J Obes (Lond); 2007 Jan; 31(1):138-46. PubMed ID: 16703004
[TBL] [Abstract][Full Text] [Related]
31. Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes.
Apovian CM; Bergenstal RM; Cuddihy RM; Qu Y; Lenox S; Lewis MS; Glass LC
Am J Med; 2010 May; 123(5):468.e9-17. PubMed ID: 20399326
[TBL] [Abstract][Full Text] [Related]
32. Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
Diabetes Prevention Program Research Group
Diabetes Care; 2019 Apr; 42(4):601-608. PubMed ID: 30877090
[TBL] [Abstract][Full Text] [Related]
33. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
34. [Progress in the prevention of type 2 diabetes].
Schernthaner G
Wien Klin Wochenschr; 2003 Nov; 115(21-22):745-57. PubMed ID: 14743578
[TBL] [Abstract][Full Text] [Related]
35. Early response to preventive strategies in the Diabetes Prevention Program.
Maruthur NM; Ma Y; Delahanty LM; Nelson JA; Aroda V; White NH; Marrero D; Brancati FL; Clark JM;
J Gen Intern Med; 2013 Dec; 28(12):1629-36. PubMed ID: 23860722
[TBL] [Abstract][Full Text] [Related]
36. Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effect.
Doggrell SA
Expert Opin Pharmacother; 2002 Jul; 3(7):1011-3. PubMed ID: 12084000
[TBL] [Abstract][Full Text] [Related]
37. Causal Effects of Intensive Lifestyle and Metformin Interventions on Cardiovascular Disease Risk Factors in Pre-Diabetic People: An Application of G-Estimation.
Salimi Y; Fotouhi A; Mohammad K; Mansournia N; Mansournia MA
Arch Iran Med; 2017 Jan; 20(1):55-59. PubMed ID: 28112533
[TBL] [Abstract][Full Text] [Related]
38. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
Aroda VR; Christophi CA; Edelstein SL; Zhang P; Herman WH; Barrett-Connor E; Delahanty LM; Montez MG; Ackermann RT; Zhuo X; Knowler WC; Ratner RE;
J Clin Endocrinol Metab; 2015 Apr; 100(4):1646-53. PubMed ID: 25706240
[TBL] [Abstract][Full Text] [Related]
39. Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.
Goldberg RB; Temprosa MG; Mather KJ; Orchard TJ; Kitabchi AE; Watson KE;
Diabetes Care; 2014 Aug; 37(8):2253-60. PubMed ID: 24824548
[TBL] [Abstract][Full Text] [Related]
40. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.
Lee A; Morley JE
Obes Res; 1998 Jan; 6(1):47-53. PubMed ID: 9526970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
